Loading...
Please wait, while we are loading the content...
Similar Documents
Hypertension and incident cardiovascular events following ibrutinib initiation
| Content Provider | Scilit |
|---|---|
| Author | Dickerson, Tyler Wiczer, Tracy Waller, Allyson Philippon, Jennifer Porter, Kyle Haddad, Devin Guha, Avirup Rogers, Kerry A. Bhat, Seema Byrd, John C. Woyach, Jennifer A. Awan, Farrukh Addison, Daniel |
| Copyright Year | 2019 |
| Description | In a retrospective analysis, Dickerson et al report that the incidence of hypertension in patients treated with ibruitinib is nearly 80% and is associated with an increased rate of adverse cardiovascular events, primarily atrial fibrillation. Cardiac events can be reduced by treating the hypertension. |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887116/pdf |
| Ending Page | 1928 |
| Page Count | 10 |
| Starting Page | 1919 |
| DOI | 10.1182/blood.2019000840 |
| Journal | Blood |
| Issue Number | 22 |
| Volume Number | 134 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2019-11-28 |
| Access Restriction | Open |
| Subject Keyword | Hematology Cardiovascular Events Fibrillation Cardiac Ibrutinib Retrospective Atrial Dickerson Ibruitinib Journal: Blood (Vol- 136, Issue- 22) |
| Content Type | Text |
| Resource Type | Article |